Old Web
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer
1997
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
30
References
14
Citations
NaN
KQI